External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database-Reference-Cited by-同舟云学术

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database

Published:2023-02 Issue:1 Volume:21 Page:175-182
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Yekedüz Emre^ORCID,Karakaya Serdar,Ertürk İsmail,Tural Deniz,Uçar Gökhan^ORCID,Şentürk Öztaş Nihan,Arıkan Rukiye,Hızal Mutlu,Küçükarda Ahmet,Sever Özlem Nuray,Arslan Çağatay,Can Orçun,Kılıçkap Saadettin,Yazgan Coşkun^ORCID,Karadurmuş Nuri,Şendur Mehmet Ali^ORCID,Çiçin İrfan,Demirci Umut,Özgüroğlu Mustafa,Öksüzoğlu Berna,Ürün Yüksel

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference16 articles.

1. Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence;Hutson;Oncologist,2011

2. Sunitinib for the treatment of metastatic renal cell carcinoma;Oudard;Cancer Treat Rev,2011

3. First-line treatment of metastatic renal cell carcinoma after COMPARZ and PISCES;Schmidinger;Curr Opin Urol,2015

4. Immunotherapy is changing first-line treatment of metastatic renal-cell carcinoma;Labriola;Clin Genitourin Cancer,2019

5. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapies in patients with favorable risk metastatic renal cell Carcinoma: A Systematic Review and Meta-Analysis;Cancer Treatment Reviews;2024-01

2. Prognostic Models in Metastatic Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2023-10